The decision was adopted in order to develop pharmaceutical industry of Uzbekistan and satisfy internal market with locally-made medicaments.

In line with the resolution of the Cabinet of Ministers of Uzbekistan “On regulation of import of ready medicaments”, the list of medicaments, at importing of which value added tax preferences, set by clause 6 of article 211 of Tax Code, will not be applied, will be introduced in Uzbekistan from 1 April 2011.

The Government of Uzbekistan also formed special working group, which will consider proposals on introduction of changes and amendments to this list.

The group was entrusted to develop a Regulation on order of introducing changes and amendments to the list and submit to approval by 1 April 2010.

According to the resolution, the regulation should determine concrete criteria of including medicaments to the list based on analysis of population illness structure, quality and satisfaction of internal market with locally-made medical products.

The working group will also conduct monitoring of pharmaceutical market of Uzbekistan and at necessity to introduce proposal to change to the list.

The new list included 45 medicaments. The list included such medicaments as ampicillin, white petrolatum, glycine, lidocaine, calcium gluconate, oksolin, paracetamol, pyracetam, cefazolin and others.

In line with clause 6 of article 211 of Tax Code, Uzbekistan exempted import of medicaments and medical (veterinary) products, raw materials for their production, from payment of value added tax.

The preference did not apply to imported ready medical products, which are produced in Uzbekistan and approved by the Government of Uzbekistan.

As earlier reported, State-Joint-Stock concern Uzpharmsanoat is planning to realize 59 projects with total cost of over US$1.086 billion within the programme on priorities of industrual develoment of Uzbekistan for 2011-2015.